Reveles Xavier Trinidad 4
4 · bioAffinity Technologies, Inc. · Filed Jan 14, 2025
Insider Transaction Report
Form 4
Reveles Xavier Trinidad
Chief Operating Officer
Transactions
- Award
Common Stock
2025-01-10+21,604→ 41,943 total
Footnotes (1)
- [F1]Grant of restricted shares of common stock that vest pro rata on a monthly basis for 12 months commencing on February 10, 2025.